Loopbaan van Robert E. Winkler
Eerdere bekende functies van Robert E. Winkler
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2018 | 19-03-2020 |
| AMICUS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 06-09-2011 | 01-09-2013 |
| ARRAY TECHNOLOGIES, INC. | Hoofd Techniek/Wetenschap/O&O | 19-05-2014 | - |
Opleiding van Robert E. Winkler
| The Hebrew University Hadassah Medical School | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Israël | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
- Beurs
- Insiders
- Robert E. Winkler
- Ervaring
